Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer.

[1]  S. Sternberg,et al.  The cardiotoxicity of adriamycin and daunomycin in children , 1976, Cancer.

[2]  D. V. Von Hoff,et al.  Risk factors for doxorubicin-induced congestive heart failure. , 1979, Annals of internal medicine.

[3]  M. Bristow,et al.  Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review. , 1986, The American journal of medicine.

[4]  Charles E. L. Brown,et al.  PERIPARTUM HEART FAILURE IN A PATIENT TREATED PREVIOUSLY WITH DOXORUBICIN , 1988, Obstetrics and gynecology.

[5]  E. Gelfand,et al.  Reversal of chronic polymyositis following intravenous immune serum globulin therapy. , 1987, JAMA.

[6]  S. Sallan,et al.  Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in children , 1981, Cancer.

[7]  J. Aarli,et al.  Guillain‐Barré syndrome: Demonstration of antibodies to peripheral nerve tissue , 1978, Acta neurologica Scandinavica.

[8]  D. Driscoll,et al.  Cardiopulmonary function in long-term survivors of childhood Hodgkin's lymphoma: a pilot study. , 1988, Mayo Clinic proceedings.

[9]  J. Ware,et al.  Echocardiographic Measurements in Normal Subjects , 1978, Circulation.

[10]  J. Mcleod,et al.  Electrophysiological studies in the Guillain‐Barré syndrome , 1981, Annals of neurology.

[11]  M. Shin,et al.  Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.